{
    "organizations": [],
    "uuid": "3da29df16aa3bcff6cab0a2ad205d8d28744acc9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-tianjin-development-to-subscribe-f/brief-tianjin-development-to-subscribe-for-wealth-management-products-idUSFWN1QJ0DF",
    "ord_in_thread": 0,
    "title": "Tianjin Development To Subscribe For Wealth Management Products",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 1 (Reuters) - Tianjin Development Holdings Ltd :\n* ‍ TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCTS IN AN AGGREGATE SUBSCRIPTION AMOUNT OF RMB350 MILLION\n* TIANJIN DEVELOPMENT -‍LISHENG PHARMACEUTICAL AND CENTRAL PHARMACEUTICAL TO SUBSCRIBE FOR INDUSTRIAL BANK WEALTH MANAGEMENT PRODUCT WORTH RMB350 MILLION​ Source text for Eikon:\n ",
    "published": "2018-03-01T17:38:00.000+02:00",
    "crawled": "2018-03-02T19:39:06.016+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "tianjin",
        "development",
        "holding",
        "ltd",
        "subscribe",
        "wealth",
        "management",
        "product",
        "aggregate",
        "subscription",
        "amount",
        "rmb350",
        "million",
        "tianjin",
        "development",
        "pharmaceutical",
        "central",
        "pharmaceutical",
        "subscribe",
        "industrial",
        "bank",
        "wealth",
        "management",
        "product",
        "worth",
        "rmb350",
        "source",
        "text",
        "eikon"
    ]
}